Filing Details

Accession Number:
0001628280-22-006443
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-16 19:28:43
Reporting Period:
2022-03-16
Accepted Time:
2022-03-16 19:28:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386570 Chromadex Corp. CDXC Medicinal Chemicals & Botanical Products (2833) 262940963
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417952 N Robert Fried 10900 Wilshire Blvd. Suite 600
Los Angeles CA 90024
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-16 25,000 $2.16 88,001 No 4 P Indirect By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 892,314 Direct
Common Stock 250,000 Indirect By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
Common Stock 250,000 Indirect By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
Common Stock 12,746 Indirect See Footnote
Footnotes
  1. The weighted average purchase price for the transaction reported was $2.16, and the range of prices were between $2.14 and $2.16, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.
  2. On August 4, 2021, 9,753 shares previously owned indirectly by Fried Films Profit Sharing were transferred to Robert N Fried IRRA.
  3. 6,745 shares held by Jeremy Fried and 6,001 shares held by Benjamin Fried, who are sons of Robert Fried.